No Data
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
New York Manufacturing Hits Low, Inflation Fears Rise
Express News | Watching Cannabis Stocks; Marijuana Moment Reports 'Trump White House Invites Proposal On Federal Marijuana Legalization, Activist Says'
Flora Announces Appointment of Patrick Moloney as Head of Product Development for Vessel
UBS Adjusts Price Target on Flora Growth to $12 From $11.50, Maintains Neutral Rating
FDA Solicits Public Comments On Use Of Cannabis-derived Products In Veterinary Medicine
